Jinnah Sindh Medical University
10 imported, source-linked research records. Published in the last five years.
10 matching research records
Topic: Canagliflozin and SGLT2. Only records linked to Jinnah Sindh Medical University are included. Historical ingestion is still running; these are imported records, not a count of all research worldwide.
Showing 1–10 of 10 matching records. Counts update as records arrive.
Differential Effects of GLP-1 Receptor Agonist and SGLT2 Inhibitor Add-on Therapy on Outcomes Following Cardiac Surgery: A Propensity Score-Matched Analysis
July 23, 2026 · 0 citations
Open original record →Correction: Effect of SGLT2 inhibitors on atrial fibrillation recurrence after catheter ablation in patients with type 2 diabetes in the United States: a TriNetX database study
February 16, 2026 · 0 citations · Open access
Open original record →Effect of SGLT2 inhibitors on atrial fibrillation recurrence after catheter ablation in patients with type 2 diabetes in the United States: a TriNetX database study
October 24, 2025 · 3 citations
Open original record →The Impact of SGLT2 Inhibitors on Pulmonary Artery Pressures and Pulmonary Hemodynamics in Patients With Heart Failure: A Systematic Review
January 1, 2025 · 3 citations · Open access
Open original record →Relationship between SGLT2 inhibitor use and specific cancer types: a systematic review and meta-analysis
September 30, 2024 · 10 citations · Open access
Open original record →Efficacy of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors in Heart Failure Management: A Narrative Review
September 29, 2024 · 0 citations · Open access
Open original record →Exploring the Cardiovascular Benefits of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors: Expanding Horizons Beyond Diabetes Management
September 30, 2023 · 60 citations · Open access
Open original record →The FDA Has Approved a New SGLT2 Inhibitor, Bexagliflozin, Which is Showing Promising Results in the Management of Type 2 Diabetes
September 4, 2023 · 2 citations
Open original record →Management of Heart Failure With Reduced Ejection Fraction in Patients With Diabetes Mellitus and Chronic Kidney Disease
May 1, 2023 · 3 citations · Open access
Open original record →Efficacy and Safety of Sodium Glucose Cotransporter-2 (SGLT2) Inhibitors in Patients With Diabetes and Chronic Kidney Disease (CKD): A Meta-analysis of Randomized Control Trials
November 26, 2022 · 3 citations · Open access
Open original record →